Pharmacokinetic Studies of Baicalin and Compatibility of Baicalin-Panax Notoginsenosides in Rat Cerebrospinal Fluid

YANG Yan-fang,LI Zhi,WANG Lei,WANG Yong-yan,ZHANG Wen-sheng
DOI: https://doi.org/10.3969/j.issn.1001-1978.2012.07.028
2012-01-01
Abstract:Aim To establish a HPLC-MS-MS method for the determination of baicalin in rat cerebrospinal fluid(CSF) and investigate the pharmacokinetics of baicalin and compatibility with Panax Notoginsenosides(PNS).Methods After baicalin and compatibility of BA-PNS were given by intravenous administration,the concentration of baicalin in rat CSF was determined by HPLC-MS-MS.Chromatographic separation was performed on an Agilent Eclipse XDB-C18(4.6 mm×150 mm,5 μm) within 7 min,with the mobile gradientphase of acetonitrile:1mmol·L-1 ammonium acetate(containing 0.1% formic acid): 0.1% ammonia.The target ion transitions were m/z 445/269(baicalin-) and m/z 237/194(Carbamazepine +).Results Calibration curves were linear over the concentration range from 5~200 μg·L-1for baicalin,with the recovery rates between 87.15%~92.73%.The pharmacokinetic parameters after a single dose of baicalin and baicalin-PNS were as follows: Cmax:(189.67±20.13),(237.00±51.86) μg·L-1;AUC0-t:(6612.96 ±1023.65),(5466.63±267.06) μg·min·L-1;AUC0-∞(6930.43±1060.41),(5682.13±412.79) μg·min·L-1;T1[]2:(108.84±45.67),(102.54±38.37) min;CL:(15.39±2.60),(18.32±0.88) L·min-1·kg-1.Conclusion The method is proved to be accurate and convenient to determine baicalin in rat cerebrospinal fluid.Baicalin can pass through blood-brain barrier and enter the cerebrospinal fluid.The pharmacokinetic parameters of baicalin have not changed,so PNS has no effect on the CSF pharmacokinetic of baicalin.
What problem does this paper attempt to address?